Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
0.9500
+0.4514 (90.53%)
Apr 17, 2025, 11:51 AM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $148.29 million as of April 17, 2025. Its market cap has decreased by -85.04% in one year.
Market Cap
148.29M
Enterprise Value
1.07M
Revenue
43.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.95
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 148.29M, a decrease of -72.46%. That is a compound annual growth rate of -24.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2025 | 148.29M | -54.35% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SS Innovations International | 1.69B |
Endo Inc. | 1.63B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 703.75M |
Northwest Biotherapeutics | 489.55M |
Elite Pharmaceuticals | 449.74M |
Glass House Brands | 419.36M |
CytoDyn | 251.42M |